Trademark: 90671821
Word
2SEVENTYBIO
Status Date
Tuesday, April 23, 2024
Filing Date
Monday, April 26, 2021
5 Pharmaceutical preparations and substances for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents and biological preparations, namely, viral vectors, all for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer
42 Pharmaceutical research and development
Apr 29, 2021
New Application Entered
Jul 31, 2021
New Application Office Supplied Data Entered
Dec 21, 2021
Assigned To Examiner
Jan 3, 2022
Non-Final Action Written
Jan 3, 2022
Non-Final Action E-Mailed
Jan 3, 2022
Notification Of Non-Final Action E-Mailed
Jun 30, 2022
Teas Response To Office Action Received
Jun 30, 2022
Correspondence Received In Law Office
Jun 30, 2022
Teas/Email Correspondence Entered
Jul 22, 2022
Suspension Letter Written
Jul 22, 2022
Letter Of Suspension E-Mailed
Jul 22, 2022
Notification Of Letter Of Suspension E-Mailed
Feb 8, 2023
Non-Final Action Written
Feb 8, 2023
Non-Final Action E-Mailed
Feb 8, 2023
Notification Of Non-Final Action E-Mailed
Mar 1, 2023
Suspension Checked - To Attorney For Action
May 2, 2023
Application Extension To Response Period - Received
May 2, 2023
Application Extension Granted/Receipt Provided
Aug 8, 2023
Teas Response To Office Action Received
Aug 8, 2023
Teas/Email Correspondence Entered
Aug 8, 2023
Correspondence Received In Law Office
Jul 5, 2024
Application Extension Granted/Receipt Provided
Jul 5, 2024
Application Extension To Response Period - Received
Apr 23, 2024
Notification Of Final Refusal Emailed
Apr 23, 2024
Final Refusal Written
Apr 23, 2024
Final Refusal E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
